PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2026Journal of Pineal Research2 citationsOpen Access

Low‐Dose Melatonin, Climacteric Symptoms and Sleep in Female Shift Workers: A Randomized Controlled Trial

View Full Paper
SSSusy Pereira SaraivaCDCarolina V. R. D'AureaCLCristina S. S. Luz

Key Points

  • This study evaluates how exogenous melatonin affects climacteric symptoms and sleep quality in female shift workers.
  • Conducted a randomized controlled trial with 46 female nurses working fixed shifts.
  • Participants received either 0.3 mg of melatonin or a placebo.
  • Data collected on sleep quality and menopausal symptoms, along with blood samples to measure reproductive hormones.
  • Melatonin treatment led to a 15.8% reduction in climacteric symptoms compared to placebo.
  • Sleep quality improved by 35.33% on days off in the melatonin group.
  • Morning shift workers saw a 32.46% improvement in sleep quality.

Abstract

ABSTRACT Sleep disturbances and mood changes are common during the climacteric, often linked to hormonal fluctuations caused by reduced ovarian function. Evidence suggests that long‐term melatonin administration may improve the quality of life in climacteric women. This study aimed to evaluate the effects of exogenous melatonin on climacteric symptoms, sleep quality, and reproductive hormones in women working fixed shifts. A randomized clinical trial was conducted with 46 nurses working fixed shifts at a hospital in São Paulo: morning (7:00–13:00, n = 16; intervention = 7, placebo = 9), afternoon (13:00–19:00, n = 15; intervention = 8, placebo = 7), and night (19:00–7:00, n = 15; intervention = 7, placebo = 8). Participants were randomly assigned to receive either 0.3 mg of melatonin or placebo. For night shift workers, melatonin was administered only on nights off, when they were sleeping at home; the same procedure was applied to morning and afternoon workers. Data collection included sociodemographic information, self‐reported sleep quality, and menopausal symptoms. Blood samples were collected at home to measure luteinizing hormone (LH), follicle‐stimulating hormone (FSH), estradiol, and progesterone before and after the intervention. A significant main effect of melatonin was observed, with a 15.8% reduction in climacteric symptoms compared with placebo ( p = 0.01), independent of age or sleep duration, while no significant interaction with work shift was detected. Sleep quality improved by 35.33% on days off in the intervention group ( p < 0.001), with morning shift workers showing a 32.46% improvement ( p < 0.05). No significant changes were observed in reproductive hormone levels or total sleep duration. Exogenous melatonin effectively alleviates climacteric symptoms and improves sleep quality on days off, particularly among day‐shift workers, without affecting reproductive hormone concentrations or total sleep duration. Trial Registration: RBR‐10whktxm (UTN: U1111‐1305‐6221). Registered on 13 August 2025, retrospectively registered.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Saraiva et al. (2026) studied this question.

synapsesocial.com/papers/69bb92df496e729e62980996https://doi.org/10.1111/jpi.70140
Ask AI
Helpful
Bookmark
Share
View Full Paper